Ownership and insider activity for Praxis Precision Medicines, Inc. (PRAX): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Praxis Precision Medicines, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to creating innovative treatments for central nervous system (CNS) conditions that stem from an imbalance in neuronal activity.
Price
| Price | $308.99 |
| Market Cap | $8.6B |
| Exchange | NASDAQ |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-07-08 | Souza Marcio | G-Gift | 20,521 | |
| 2026-07-08 | Souza Marcio | G-Gift | 2,600 | |
| 2026-06-24 | DeSimone Jill | M-Exempt | 3,034 | $447K |
| 2026-06-24 | DeSimone Jill | S-Sale | 10 | $3K |
| 2026-06-24 | DeSimone Jill | S-Sale | 120 | $36K |
| 2026-06-24 | DeSimone Jill | S-Sale | 320 | $98K |
| 2026-06-24 | DeSimone Jill | S-Sale | 683 | $210K |
| 2026-06-24 | DeSimone Jill | S-Sale | 1,240 | $382K |
| 2026-06-24 | DeSimone Jill | M-Exempt | 8,566 | $379K |
| 2026-06-24 | DeSimone Jill | S-Sale | 999 | $309K |
Balance Sheet (10y)
| Year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $17.9M | $44.8M | $296.6M | $138.7M | $61.6M | $81.3M | $215.4M | $357.3M |
| Short-term Investments | 0 | 0 | 0 | $137.2M | $38.9M | 0 | $177.2M | $242.0M |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | $19.1M | $45.5M | $302.3M | $287.4M | $110.8M | $84.9M | $404.4M | $610.9M |
| Property, Plant & Equipment | $103000 | $1.6M | $836000 | $4.9M | $3.9M | $2.7M | $1.4M | $239000 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | $19.8M | $47.7M | $303.2M | $292.7M | $115.1M | $87.9M | $483.1M | $937.9M |
| Accounts Payable | $3.4M | $2.7M | $4.1M | $10.8M | $14.7M | $5.8M | $12.5M | $24.6M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | $5.1M | $6.8M | $15.7M | $38.4M | $34.3M | $15.7M | $37.5M | $59.8M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | $5.1M | $7.6M | $15.7M | $41.9M | $39.0M | $18.3M | $37.7M | $59.8M |
| Retained Earnings | -$41.4M | -$81.0M | -$149.6M | -$316.6M | -$530.6M | -$653.9M | -$836.7M | -$1.14B |
| Total Equity | $14.7M | $40.1M | $287.5M | $250.8M | $76.1M | $69.7M | $445.4M | $878.1M |
| Total Debt | 0 | $1.5M | $763000 | $4.3M | $3.5M | $2.5M | $1.4M | $110000 |
| Net Debt | -$17.9M | -$43.4M | -$295.8M | -$271.6M | -$97.0M | -$78.8M | -$391.2M | -$599.2M |
| Working Capital | $14.0M | $38.7M | $286.6M | $249.0M | $76.5M | $69.1M | $366.8M | $551.1M |
Financial Health
| Debt / Equity | 0.00 |
| Current Ratio | 15.73 |
Profitability
| Gross Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
Related companies: ACAD · AKRO · CNTA · CRNX · IMVT · KYMR · LGND
Explore sector: Healthcare · Biotechnology
More sections of PRAX: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks